|
1
|
Bulun SE: Endometriosis. N Engl J Med.
360:268–279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sampson JA: Endometrial carcinoma of the
ovary arising in endometrial tissue in that organ. Arch Surg.
10:1–72. 1925. View Article : Google Scholar
|
|
3
|
Kobayashi H, Sumimoto K, Moniwa N, et al:
Risk of developing ovarian cancer among women with ovarian
endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol
Cancer. 17:37–43. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stern RC, Dash R, Bentley RC, Snyder MJ,
Haney AF and Robboy SJ: Malignancy in endometriosis: frequency and
comparison of ovarian and extraovarian types. Int J Gynecol Pathol.
20:133–139. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshikawa H, Jimbo H, Okada S, et al:
Prevalence of endometriosis in ovarian cancer. Gynecol Obstet
Invest. 50(Suppl 1): 11–17. 2000. View Article : Google Scholar
|
|
6
|
Shih Ie M and Kurman RJ: Ovarian
tumorigenesis: a proposed model based on morphological and
molecular genetic analysis. Am J Pathol. 164:1511–1518.
2004.PubMed/NCBI
|
|
7
|
Park SY, Kwon HJ, Lee HE, et al: Promoter
CpG island hypermethylation during breast cancer progression.
Virchows Arch. 458:73–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martini M, Ciccarone M, Garganese G, et
al: Possible involvement of hMLH1, p16(INK4a) and
PTEN in the malignant transformation of endometriosis. Int J
Cancer. 102:398–406. 2002.
|
|
9
|
Levanon D, Negreanu V, Bernstein Y, Bar-Am
I, Avivi L and Groner Y: AML1, AML2, and AML3, the human members of
the runt domain gene-family: cDNA structure, expression, and
chromosomal localization. Genomics. 23:425–432. 1994.PubMed/NCBI
|
|
10
|
Uno S, Zembutsu H, Hirasawa A, et al: A
genome-wide association study identifies genetic variants in the
CDKN2BAS locus associated with endometriosis in Japanese.
Nat Genet. 42:707–710. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Habtemariam B, Anisimov VM and MacKerell
AD Jr: Cooperative binding of DNA and CBFβ to the Runt domain of
the CBFα studied via MD simulations. Nucleic Acids Res.
33:4212–4222. 2005.
|
|
12
|
Li QL, Ito K, Sakakura C, et al: Causal
relationship between the loss of RUNX3 expression and
gastric cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zaidi SK, Sullivan AJ, van Wijnen AJ,
Stein JL, Stein GS and Lian JB: Integration of Runx and Smad
regulatory signals at transcriptionally active subnuclear sites.
Proc Natl Acad Sci USA. 99:8048–8053. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Subramaniam MM, Chan JY, Soong R, et al:
RUNX3 inactivation by frequent promoter hypermethylation and
protein mislocalization constitute an early event in breast cancer
progression. Breast Cancer Res Treat. 113:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshizaki T, Enomoto T, Fujita M, et al:
Frequent inactivation of RUNX3 in endometrial carcinoma.
Gynecol Oncol. 110:439–444. 2008. View Article : Google Scholar
|
|
16
|
Dhillon VS, Shahid M and Husain SA:
CpG methylation of the FHIT, FANCF,
cyclin-D2, BRCA2 and RUNX3 genes in Granulosa
cell tumors (GCTs) of ovarian origin. Mol Cancer. 3:332004.
View Article : Google Scholar
|
|
17
|
Kato N, Tamura G, Fukase M, Shibuya H and
Motoyama T: Hypermethylation of the RUNX3 gene promoter in
testicular yolk sac tumor of infants. Am J Pathol. 163:387–391.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng AS, Culhane AC, Chan MW, et al:
Epithelial progeny of estrogen-exposed breast progenitor cells
display a cancer-like methylome. Cancer Res. 68:1786–1796. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oxholm D, Knudsen UB, Kryger-Baggesen N
and Ravn P: Postmenopausal endometriosis. Acta Obstet Gynecol
Scand. 86:1158–1164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scott RB: Malignant changes in
endometriosis. Obstet Gynecol. 2:283–289. 1953.
|
|
21
|
Jones PA: The DNA methylation paradox.
Trends Genet. 15:34–37. 1999. View Article : Google Scholar
|
|
22
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010. View Article : Google Scholar
|
|
23
|
Senthong A, Kitkumthorn N, Rattanatanyong
P, Khemapech N, Triratanachart S and Mutirangura A: Differences in
LINE-1 methylation between endometriotic ovarian cyst and
endometriosis-associated ovarian cancer. Int J Gynecol Cancer.
24:36–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zochbauer-Muller S, Fong KM, Maitra A, et
al: 5′ CpG island methylation of the FHIT gene is correlated
with loss of gene expression in lung and breast cancer. Cancer Res.
61:3581–3585. 2001.
|
|
25
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
27
|
Wang H, Feng Y, Bao Z, et al: Epigenetic
silencing of KAZALD1 confers a better prognosis and is associated
with malignant transformation/progression in glioma. Oncol Rep.
30:2089–2096. 2013.PubMed/NCBI
|
|
28
|
Falkenberry SS, Steinhoff MM, Gordinier M,
Rappoport S, Gajewski W and Granai CO: Synchronous endometrioid
tumors of the ovary and endometrium. A clinicopathologic study of
22 cases. J Reprod Med. 41:713–718. 1996.PubMed/NCBI
|
|
29
|
Zaino R, Whitney C, Brady MF, DeGeest K,
Burger RA and Buller RE: Simultaneously detected endometrial and
ovarian carcinomas - a prospective clinicopathologic study of 74
cases: a Gynecologic Oncology Group study. Gynecol Oncol.
83:355–362. 2001. View Article : Google Scholar
|
|
30
|
Kurman RJ and Shih IeM: Pathogenesis of
ovarian cancer: lessons from morphology and molecular biology and
their clinical implications. Int J Gynecol Pathol. 27:151–160.
2008.PubMed/NCBI
|
|
31
|
Martin DC: Cancer and endometriosis: do we
need to be concerned? Semin Reprod Endocrinol. 15:319–324. 1997.
View Article : Google Scholar
|
|
32
|
Vigano P, Somigliana E, Chiodo I, Abbiati
A and Vercellini P: Molecular mechanisms and biological
plausibility underlying the malignant transformation of
endometriosis: a critical analysis. Hum Reprod Update. 12:77–89.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Van Gorp T, Amant F, Neven P, Vergote I
and Moerman P: Endometriosis and the development of malignant
tumours of the pelvis. A review of literature. Best Pract Res Clin
Obstet Gynaecol. 18:349–371. 2004.PubMed/NCBI
|
|
34
|
Rosenblatt KA and Thomas DB: Reduced risk
of ovarian cancer in women with a tubal ligation or hysterectomy.
The World Health Organization Collaborative Study of Neoplasia and
Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev.
5:933–935. 1996.
|
|
35
|
Ren F, Wang D, Jiang Y and Ren F:
Epigenetic inactivation of hMLH1 in the malignant transformation of
ovarian endometriosis. Arch Gynecol Obstet. 285:215–221. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suzuki M, Shigematsu H, Shames DS, et al:
DNA methylation-associated inactivation of TGFβ-related
genes DRM/Gremlin, RUNX3, and HPP1 in human
cancers. Br J Cancer. 93:1029–1037. 2005. View Article : Google Scholar
|
